U.S. Interactive Media and Services Stock News

NYSE:T
NYSE:TTelecom

AT&T Joins Rivals On Satellite Venture To Rework Coverage Story

AT&T (NYSE:T), Verizon, and T-Mobile have created a joint venture to use satellite-based technologies to reduce mobile dead zones in the U.S. The initiative targets rural and underserved regions and seeks to extend coverage to areas that traditional towers do not reach. The collaboration is intended to improve network resilience during events like natural disasters by adding satellite-backed redundancy. The effort is expected to support ecosystem partners such as AST SpaceMobile and could...
NYSE:PRM
NYSE:PRMChemicals

Why Perimeter Solutions (PRM) Is Up 23.7% After Strong Q1 Earnings And Disciplined M&A Update

Perimeter Solutions, Inc. recently reported first-quarter 2026 results, with sales rising to US$125.07 million and net income reaching US$72.94 million, alongside higher earnings per share versus a year earlier. Management also highlighted an active mergers and acquisitions pipeline, emphasizing a repeatable “small but essential component” acquisition model that focuses on recurring revenue and operational improvement after deals close. We’ll now examine how Perimeter Solutions’ strong...
NYSE:ORA
NYSE:ORARenewable Energy

Why Ormat Technologies (ORA) Is Up 16.1% After Record Q1 Revenue And Reaffirmed 2026 Guidance

In early May 2026, Ormat Technologies, Inc. reported first-quarter revenue of US$403.91 million and net income of US$44.07 million, reaffirmed its 2026 revenue guidance of US$1.11–1.16 billion, recognized US$8.11 million in long-lived asset impairments, and declared a quarterly dividend of US$0.12 per share. An interesting aspect of this update is that Ormat combined record quarterly revenue and slightly higher earnings per share with fresh asset impairments, a recently completed US$1.00...
NYSE:DDS
NYSE:DDSMultiline Retail

Dividend Fortresses Three High Yields With Very Different Stories

High inflation risks, sticky interest rates and energy driven cost pressures have pushed many investors toward income they can see and touch. That is where the Dividend Fortresses screener comes in, focusing on stocks with dividend yields above 5% that aim to offer both resilience and meaningful cash payouts. Instead of trying to guess the next macro twist, you can look at companies that already return a high share of cash to shareholders. In this article you will see three stocks from the...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

A Look At Tradeweb Markets (TW) Valuation After Recent Share Price Cooling And Mixed Fair Value Signals

Tradeweb Markets overview and recent share performance Tradeweb Markets (TW) operates electronic marketplaces across fixed income, equities, and money markets. Its stock has recently drawn attention after a period in which returns have moved differently across time frames. Over the past month, the stock is down about 11%, and down roughly 5% over the past 3 months, while the year to date return is a gain of about 3%. Looking back one year, the total return has fallen about 21%, compared with...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

Evaluating Gold Royalty (GROY) After A Profit-Making Quarter And Strong Revenue Performance

Gold Royalty (GROY) has attracted attention after reporting first quarter 2026 earnings with sales of US$7.18 million and net income of US$1.77 million, a shift from a loss in the prior year period. See our latest analysis for Gold Royalty. The share price sits at US$3.73, with a 7 day share price return of 5.97% and a 90 day share price return that is down 11.19%. The 1 year total shareholder return of 152.03% indicates strong longer term momentum despite recent volatility and follows...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

BioCryst’s Navenibart Deal And Pediatric Data Shape HAE Investment Case

BioCryst Pharmaceuticals (NasdaqGS:BCRX) has granted Neopharmed Gentili exclusive European licensing rights to navenibart for hereditary angioedema. The agreement includes an upfront payment and potential future milestone payments to BioCryst. Neopharmed Gentili is expected to use its existing European commercial infrastructure to support the rollout of navenibart. At ISPOR 2026, BioCryst presented real world evidence on pediatric hereditary angioedema highlighting ongoing medical and...
NYSE:PEG
NYSE:PEGIntegrated Utilities

Is Public Service Enterprise Group (PEG) Offering Value After Recent Pullback In Share Price?

If you are wondering whether Public Service Enterprise Group (PEG) stock still offers solid value at current levels, it helps to start with how its recent price and fundamentals line up. The share price closed at US$77.22, with returns that declined 2.7% over the past week and 5.0% over the past month, while sitting up 3.1% over 1 year and 47.2% over 5 years. These figures can influence how investors view both upside potential and risk. Recent news coverage has focused on PEG as a large...
NYSE:ADM
NYSE:ADMFood

A Look At Archer Daniels Midland (ADM) Valuation After Q1 2026 Beat And Raised EPS Outlook

Archer-Daniels-Midland (ADM) is back in focus after better-than-expected Q1 2026 profitability and a higher full-year adjusted EPS outlook, supported by stronger soybean crush, improved ethanol margins, and a recovering Nutrition segment. See our latest analysis for Archer-Daniels-Midland. The Q1 earnings beat and higher full-year guidance have coincided with a sharp pick up in momentum, with a 30-day share price return of 18.7% and year-to-date share price return of 40.4%. In addition, the...